MEIS2 and pachyonychia congenita: Moreover, previous PC studies have shown that MEIS2 transcriptional and protein expression levels decrease gradually from non-malignant prostate to primary PC and to metastatic PC tissue samples, suggesting that MEIS2 plays a tumor suppressive role and may be involved in PC development and/or progression [16, 17].